Skip to main content

Lipid-lowering drugs

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.


Although a change in life-style is often the method of first choice for lipid lowering, lipid-lowering drugs, in general, help to control elevated levels of different forms of lipids in patients with hyperlipidemia. While one group of drugs, statins, lowers cholesterol, the other group, fibrates, is known to take care of fatty acids and triglycerides. In addition, other drugs, such as ezetimibe, colesevelam, torcetrapib, avasimibe, implitapide, and niacin are also being considered to manage hyperlipidemia. As lipids are very critical for cardiovascular diseases, these drugs reduce fatal and nonfatal cardiovascular abnormalities in the general population. However, a number of recent studies indicate that apart from their lipidlowering activities, statins and fibrates exhibit multiple functions to modulate intracellular signaling pathways, inhibit inflammation, suppress the production of reactive oxygen species, and modulate T cell activity. Therefore, nowadays, these drugs are being considered as possible therapeutics for several forms of human disorders including cancer, autoimmunity, inflammation, and neurodegeneration. Here I discuss these applications in the light of newly discovered modes of action of these drugs.

This is a preview of subscription content, access via your institution.

Author information

Authors and Affiliations


Corresponding author

Correspondence to K. Pahan.

Additional information

Received 5 September 2005; received after revision 29 December 2005; accepted 26 January 2006

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pahan, K. Lipid-lowering drugs. Cell. Mol. Life Sci. 63, 1165–1178 (2006).

Download citation

  • Published:

  • Issue Date:

  • DOI: